The conversation reveals a concerning trend in the rising number of young patients prescribed psychiatric medications, including recent approvals for drugs like Lexapro for children as young as seven. Many doctors express disbelief at the volume of these prescriptions, often discovering them during routine visits. The discussion highlights the role of pediatricians in initiating these prescriptions, raising questions about the oversight and implications for young patients.
